Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Showcase Companies

Stockhouse is proud to showcase a portfolio of companies that we are watching closely. Learn more about these companies as part of your own investment research. Consider using the tools below to be first in line for important news and updates. view all showcase companies

Cipher Pharmaceuticals Inc T.CPH

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.

Latest News

Cipher Pharmaceuticals Strengthens Leadership Team with Appointment of New CFO


Cipher Pharmaceuticals Reports Second Quarter 2022 Financial Results


Cipher Pharmaceuticals Schedules Q2 2022 Earnings Release and Conference Call


Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders and Thanks...


Cipher Pharmaceuticals Reports Strong First Quarter 2022 Financial Results


Cipher Pharmaceuticals Schedules Q1 2022 Earnings Release and Conference Call


Cipher Pharmaceuticals Announces Partner, Moberg Pharma's Regulatory Submission to FDA for North...


Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results


Cipher Pharmaceuticals Schedules Q4 2021 Earnings Release and Conference Call


Cipher Pharmaceuticals Announces Extension of Distribution and Supply Agreement with Sun...


Cipher (TSX:CPH) announces Q3 and year-to-date 2021 financial results


Cipher Announces Third Quarter and Year-to-Date 2021 Financial Results


Cipher Pharmaceuticals Schedules Q3 2021 Earnings Release and Conference Call


Cipher Pharmaceuticals Announces Renewal of Normal Course Issuer Bid


Cipher Reports 30% Revenue Growth and 40% Adjusted EBITDA Growth in Second Quarter of 2021...